THE LAB TEST, REINVENTED

WIPO WIPO 2015

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark THE LAB TEST, REINVENTED was filed as Word mark on 10/12/2015 at the World Intellectual Property Organization.

Trademark Details Last update: April 2, 2019

Trademark form Word mark
File reference 1290371
Countries Australia Switzerland China European Community Ireland India Japan South Korea Mexico Norway Philippines Russia Singapore
Base trademark US No. 86667635, June 18, 2015
Application date October 12, 2015
Expiration date August 27, 2018

Trademark owner

1701 Page Mill Road
Palo Alto, CA 94304
US

Trademark representatives

801 California Street, Silicon Valley Center US

goods and services

09 Computer software for healthcare monitoring; computer software for communicating medical test results to patients; computer software for communicating medical test results to service providers in the medical and healthcare fields; computer software for scheduling a laboratory test appointment; computer software for appointment scheduling; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for use in biomonitoring of humans and of animals; computer software for medical monitoring and analysis of medical data; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; mobile electronic devices, namely, tablet computers, mobile phones, personal digital assistants, and other cellular or wireless communication devices; downloadable electronic publications, namely, downloadable newsletters, blogs, e-zines, magazines, books, manuals, pamphlets, diaries and journals in the fields of healthcare, medicine, personal health and fitness, biomonitoring, medical diagnostics, monitoring and testing
35 Administering pharmacy reimbursement programs and services; Administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; administrative services relating to medical referrals; administrative services relating to physician referrals; medical billing support services; providing an internet-based database of patient medical information designed to facilitate sharing and maintenance of patient medical information between and amongst the patient and healthcare professionals providing services to the patient; maintaining patient medical records and files
36 Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services
42 Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services for scientific research purposes; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical research laboratory services; providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing via a web site technology that enables patients, physicians and other healthcare providers to generate, manage and exchange medical information
44 Medical evaluation services; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services; health care; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes; providing information in the field of pet health; pet hospital services; providing via a web site medical information; providing via a website health and healthcare information; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary special services

Trademark history

Date Document number Area Entry
March 8, 2019 2019/13 Gaz US RAW: Total Ceasing Effect
August 3, 2018 2018/38 Gaz SG Rejection
April 6, 2018 2018/18 Gaz NO Rejection
March 27, 2018 2018/17 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 16, 2018 2018/15 Gaz PH RAW: Rule 18ter(2)(i) GP following a provisional refusal
February 28, 2018 2018/10 Gaz MX RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 25, 2018 2018/4 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
January 19, 2018 2018/4 Gaz CH RAW: Rule 18ter(2)(i) GP following a provisional refusal
December 26, 2017 2018/2 Gaz RU Rejection
September 8, 2017 2017/44 Gaz RAW: Limitation
June 27, 2017 2017/27 Gaz CN Rejection
April 12, 2017 2017/17 Gaz KR Rejection
March 22, 2017 2017/12 Gaz MX Rejection
March 7, 2017 2017/12 Gaz IN Rejection
January 30, 2017 2017/6 Gaz RU Rejection
January 25, 2017 2017/7 Gaz CH Rejection
January 18, 2017 2017/23 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 14, 2016 2016/46 Gaz NO Rejection
October 13, 2016 2016/43 Gaz JP Rejection
September 29, 2016 2016/41 Gaz KR Rejection
September 29, 2016 2017/15 Gaz IE Rejection
June 22, 2016 2016/26 Gaz AU Rejection
May 5, 2016 2016/21 Gaz SG Rejection
April 18, 2016 2016/21 Gaz IE Rejection
March 10, 2016 2016/12 Gaz PH Rejection
March 9, 2016 2016/13 Gaz EM Rejection
October 12, 2015 2016/8 Gaz US Registration

ID: 141290371